Back to top
Read MoreHide Full Article

Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 20th:

H&E Equipment Services, Inc. (HEES - Free Report) : This integrated equipment services company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.8% over the last 60 days.

H&E Equipment Services, Inc. Price and Consensus

This Zacks Rank #1 (Buy) company has a dividend yield of 2.81%, compared with the industry average of 0.71%. Its five-year average dividend yield is 3.30%.

H&E Equipment Services, Inc. Dividend Yield (TTM)

BCB Bancorp, Inc. (BCBP - Free Report) : This bank holding company has witnessed the Zacks Consensus Estimate for its current year earnings advancing 10.8% over the last 60 days.

BCB Bancorp, Inc. (NJ) Price and Consensus

This Zacks Rank #2 (Buy) company has a dividend yield of 3.84%, compared with the industry average of 1.43%. Its five-year average dividend yield is 4.56%.

BCB Bancorp, Inc. (NJ) Dividend Yield (TTM)

Escalade, Incorporated (ESCA - Free Report) : This sporting goods seller has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.

Escalade, Incorporated Price and Consensus

This Zacks Rank #2 (Buy) company has a dividend yield of 3.43%, compared with the industry average of 0.00%. Its five-year average dividend yield is 3.60%.

Escalade, Incorporated Dividend Yield (TTM)

Statoil ASA (STO - Free Report) : This energy company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days.

Statoil ASA Price and Consensus

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.68%, compared with the industry average of 2.76%. Its five-year average dividend yield is 4.44%.

Statoil ASA Dividend Yield (TTM)

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



More from Zacks Zacks #1 Rank Additions

You May Like